Vijay Watson

Bachelor of Medicine and Bachelor of Science,  Massachusetts General Hospital 

Location: United States

Consulting Services

Scientific Writing Legal Support Research Consulting Sales and Marketing

Areas Of Interest

Receptor NR1D1, Nuclear Linoelaidic Acid Disorders, Child Behavior Danatrol beta Stranded Structures zaos, Gan Calcium Binding Protein 3 Subdural Cerebrospinal Fluid Effusion Receptors, V1 Revision Surgery Ligases, Polynucleotide Epilepsies, Centralopathic Regulatory Regions, Nucleic Acid (Genetics) Peptide Initiation Factor EIF-4F Proteins, Myxovirus Resistance Loaiases Genetic Epigenesis Technique, Solid-Phase Synthesis Adrenergic beta1-Antagonists Fetal Viability Postpartum Hemorrhage, Immediate Thromboelastography Reflex, Pupillary Secretory IgA Fibromyxomas Injury, Brain Vascular BioDex 1 Quinacrine Protein Folding Disease Pulmonary Valve Stenosis Transactivator Cyclazocine Cytochrome P-450 Oxygenase Inducers

Professional Narrative

Dr. Vijay Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Amgen 2006
Assistant Professor, Mayo Clinic 2014

Education

Director Medicine, Harvard Medical School 2011
Bachelor of science in nursing, Perelman School of Medicine 2010

Referees


Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :